Immuneering Corp·4

Dec 22, 5:30 PM ET

Hall Brett Matthew 4

4 · Immuneering Corp · Filed Dec 22, 2021

Insider Transaction Report

Form 4
Period: 2021-12-22
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Class A Common Stock

    2021-12-22+322,691329,084 total
Footnotes (1)
  • [F1]Calculated using a value based on the average of the daily volume weighted average prices of the Class A common stock on the Nasdaq Stock Exchange for the 30-trading day period ending on and including the trading day immediately prior to the Closing Date, as that term is defined in the Share Purchase Agreement, dated as of December 22, 2021, by and among Immuneering Corporation, BioArkive, Inc. ("BioArkive"), and each of the shareholders of BioArkive, including Dr. Hall.

Documents

1 file
  • 4
    form4-12222021_021254.xmlPrimary